Literature DB >> 24030399

Altered apoptosis-related signaling after cardioplegic arrest in patients with uncontrolled type 2 diabetes mellitus.

Jun Feng1, Yuhong Liu, Nikola Dobrilovic, Louis M Chu, Cesario Bianchi, Arun K Singh, Frank W Sellke.   

Abstract

BACKGROUND: We investigated the effects of cardioplegic arrest and reperfusion (CP/Rep) on myocardial apoptosis and key apoptotic mediators, such as apoptosis-inducing factor, caspase 3, caspase 8, caspase 9, poly(adenosine diphosphate-ribose) polymerase, B-cell lymphoma 2 (Bcl-2) family proteins, and protein kinase C (PKC), in uncontrolled type 2 diabetic, controlled type 2 diabetic, and nondiabetic patients. METHODS AND
RESULTS: Right atrial tissue was harvested pre- and post-CP/Rep from uncontrolled type 2 diabetic patients (hemoglobin A1c=9.6 ± 0.25), controlled type 2 diabetic patients (hemoglobin A1c=6.5 ± 0.15), and nondiabetic patients (hemoglobin A1c=5.4 ± 0.12) undergoing coronary artery bypass grafting (n=8/group). Terminal deoxynucleotidyl transferase dUTP nick-end labeling staining was used for the identification of apoptotic cells. Total and modified apoptosis-inducing factor, Bcl-2 family proteins, phospho-PKC-α, phospho-PKC-β1, and poly(adenosine diphosphate-ribose) polymerase were quantified by immunoblotting or immunohistochemistry. At baseline, the number of apoptotic cells and expression of total apoptosis-inducing factor, Bcl-2, Bak, and Bax in the pre-CP/Rep atrial tissue from uncontrolled type 2 diabetic patients were significantly increased compared with those of nondiabetic or controlled type 2 diabetic patients (P<0.05). After CP/Rep, the amount of apoptotic cells, apoptosis-inducing factor, phospho-Bad, phospho-PKC-α, phospho-PKC-β1, and cleaved poly(adenosine diphosphate-ribose) polymerase in post-CP/Rep atrial tissue were increased in all 3 groups compared with pre-CP/Rep. These increases after CP/Rep were more pronounced in the uncontrolled type 2 diabetic group. In addition, there were significant increases in the expression of cleaved caspase 8 and caspase 9 in the basal and post-CP/Rep atrium of uncontrolled type 2 diabetic group compared with nondiabetic or controlled type 2 diabetic group.
CONCLUSIONS: Uncontrolled diabetes mellitus is associated with increases in myocardial apoptosis and expression of key apoptosis mediators at baseline and in the setting of CP/Rep.

Entities:  

Keywords:  apoptosis; cardioplegia; cardiopulmonary bypass; coronary artery bypass surgery; diabetes mellitus

Mesh:

Substances:

Year:  2013        PMID: 24030399      PMCID: PMC3815526          DOI: 10.1161/CIRCULATIONAHA.112.000332

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

1.  Bradykinin preconditioning improves the profile of cell survival proteins and limits apoptosis after cardioplegic arrest.

Authors:  Jun Feng; Cesario Bianchi; Jennifer L Sandmeyer; Frank W Sellke
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

2.  Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Authors:  Faramarz Ismail-Beigi; Timothy Craven; Mary Ann Banerji; Jan Basile; Jorge Calles; Robert M Cohen; Robert Cuddihy; William C Cushman; Saul Genuth; Richard H Grimm; Bruce P Hamilton; Byron Hoogwerf; Diane Karl; Lois Katz; Armand Krikorian; Patrick O'Connor; Rodica Pop-Busui; Ulrich Schubart; Debra Simmons; Harris Taylor; Abraham Thomas; Daniel Weiss; Irene Hramiak
Journal:  Lancet       Date:  2010-06-30       Impact factor: 79.321

3.  Indices of apoptosis activation after blood cardioplegia and cardiopulmonary bypass.

Authors:  Basel Ramlawi; Jun Feng; Shigetoshi Mieno; Csaba Szabo; Zsuzsanna Zsengeller; Richard Clements; Neel Sodha; Munir Boodhwani; Cesario Bianchi; Frank W Sellke
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

4.  Effects of medical therapies on retinopathy progression in type 2 diabetes.

Authors:  Emily Y Chew; Walter T Ambrosius; Matthew D Davis; Ronald P Danis; Sapna Gangaputra; Craig M Greven; Larry Hubbard; Barbara A Esser; James F Lovato; Letitia H Perdue; David C Goff; William C Cushman; Henry N Ginsberg; Marshall B Elam; Saul Genuth; Hertzel C Gerstein; Ulrich Schubart; Lawrence J Fine
Journal:  N Engl J Med       Date:  2010-06-29       Impact factor: 91.245

5.  Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting.

Authors:  V H Thourani; W S Weintraub; B Stein; S S Gebhart; J M Craver; E L Jones; R A Guyton
Journal:  Ann Thorac Surg       Date:  1999-04       Impact factor: 4.330

6.  Selective blockade of protein kinase B protects the rat and human myocardium against ischaemic injury.

Authors:  José Linares-Palomino; Muhammad A Husainy; Vien K Lai; John M Dickenson; Manuel Galiñanes
Journal:  J Physiol       Date:  2010-04-19       Impact factor: 5.182

7.  Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass.

Authors:  Robert M Osipov; Michael P Robich; Jun Feng; Vincent Chan; Richard T Clements; Ralph J Deyo; Csaba Szabo; Frank W Sellke
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-01-05

8.  Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: role of caspases and poly-adenosine diphosphate-ribose polymerase.

Authors:  Mohammed F Chowdhry; Hunaid A Vohra; Manuel Galiñanes
Journal:  J Thorac Cardiovasc Surg       Date:  2007-07       Impact factor: 5.209

9.  Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes.

Authors:  S Ares-Carrasco; B Picatoste; A Benito-Martín; I Zubiri; A B Sanz; M D Sánchez-Niño; A Ortiz; J Egido; J Tuñón; O Lorenzo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-09       Impact factor: 4.733

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

View more
  12 in total

1.  Differential impairment of adherens-junction expression/phosphorylation after cardioplegia in diabetic versus non-diabetic patients.

Authors:  Jun Feng; Yuhong Liu; Ashraf A Sabe; Ahmed A Sadek; Arun K Singh; Neel R Sodha; Frank W Sellke
Journal:  Eur J Cardiothorac Surg       Date:  2015-06-11       Impact factor: 4.191

2.  Diabetes and Cardioplegia.

Authors:  Brittany A Potz; Laura A Scrimgeour; Jun Feng; Frank W Sellke
Journal:  J Nat Sci       Date:  2017-06

3.  Effects of diabetes and cardiopulmonary bypass on expression of adherens junction proteins in human peripheral tissue.

Authors:  Jun Feng; Yuhong Liu; Arun K Singh; Afshin Ehsan; Nicholas Sellke; Justin Liang; Frank W Sellke
Journal:  Surgery       Date:  2016-11-09       Impact factor: 3.982

4.  New continuous-flow total artificial heart and vascular permeability.

Authors:  Jun Feng; William E Cohn; Steven M Parnis; Neel R Sodha; Richard T Clements; Nicholas Sellke; O Howard Frazier; Frank W Sellke
Journal:  J Surg Res       Date:  2015-06-18       Impact factor: 2.192

5.  Glycemic control is not associated with neurocognitive decline after cardiac surgery.

Authors:  Laura A Scrimgeour; Ian Ikeda; Nicholas C Sellke; Guangbin Shi; Jun Feng; Sevdenur Cizginer; Afshin Ehsan; Neel R Sodha; Frank W Sellke
Journal:  J Card Surg       Date:  2021-10-28       Impact factor: 1.620

Review 6.  Microvascular dysfunction in patients with diabetes after cardioplegic arrest and cardiopulmonary bypass.

Authors:  Jun Feng; Frank Sellke
Journal:  Curr Opin Cardiol       Date:  2016-11       Impact factor: 2.161

7.  Impaired coronary contraction to phenylephrine after cardioplegic arrest in diabetic patients.

Authors:  Nicholas Sellke; Caroline Gordon; Isabella Lawandy; Anastassia Y Gorvitovskaia; Laura A Scrimgeour; James G Fingleton; Frank W Sellke; Jun Feng
Journal:  J Surg Res       Date:  2018-05-22       Impact factor: 2.192

Review 8.  Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease.

Authors:  Maria I Avrutsky; Carol M Troy
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.988

9.  Effects of 1,25-dihydroxyvitamin D3 on pathological changes in rats with diabetic cardiomyopathy.

Authors:  Xiaoyun Zeng; Xintian Yu; Shan Xiao; Hua Yao; Jun Zhu
Journal:  Lipids Health Dis       Date:  2017-06-08       Impact factor: 3.876

10.  Naringenin accords hepatoprotection from streptozotocin induced diabetes in vivo by modulating mitochondrial dysfunction and apoptotic signaling cascade.

Authors:  Radhika Kapoor; Poonam Kakkar
Journal:  Toxicol Rep       Date:  2014-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.